Guidance for Arrhythmia Research Technology, Inc. (HRT)
| Period | Range | Estimate | Revenue Range | Revenue Estimate | Target | Details |
|---|---|---|---|---|---|---|
| 2023 | $1.05 – $1.10 | $1.04 | $720.00M – 735.00M | $724.90M | = Maintained | Details |
| 2023 | $1.30 – $1.43 | $1.34 | $720.00M – 745.00M | $731.00M | = Maintained | Details |
| 2023 | N/A | N/A | $720.00M – 745.00M | $750.50M | = Maintained | Details |
| 2022 | $1.64 – $1.76 | $1.57 | $820.00M – 830.00M | $822.37M | = Maintained | Details |
| 2022 | $1.51 – $1.64 | $1.22 | $815.00M – 825.00M | $807.70M | = Maintained | Details |
| 2022 | $1.32 – $1.45 | $0.67 | $805.00M – 820.00M | $769.00M |  Raised |
Details |
| 2021 | N/A | N/A | $713.00M – 716.00M | N/A | = Maintained | Details |
